• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Motus GI Holdings, Inc. (Amendment)

    12/29/21 4:28:32 PM ET
    $MOTS
    Medical/Dental Instruments
    Health Care
    Get the next $MOTS alert in real time by email
    SC 13G/A 1 tm2136521d1_sc13ga.htm SC 13G/A

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13G/A

    Amendment No 3* (Exit Filing)

     

    Under the Securities Exchange Act of 1934

     

    MOTUS GI HOLDINGS, INC.

    (Name of Issuer)

     

    Common Stock

    (Title of Class of Securities)

     

    62014P108

    (CUSIP Number)

     

    December 22, 2021

    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ¨Rule 13d-1(b)

    xRule 13d-1(c)

    ¨Rule 13d-1(d)

     

    * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

     

    1

    NAME OF REPORTING PERSONS

    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

     

    Larry N. Feinberg

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

    (a) ¨

    (b) ¨

    3

    SEC USE ONLY

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    United States

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    105,885

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    105,885

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    105,885

    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    0.22% *

    12

    TYPE OF REPORTING PERSON (See Instructions)

     

    IN

    * This percentage is based on a total of 48,277,438 shares of the Issuer’s common stock (the “Shares”) outstanding as of November 4, 2021, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities Exchange Commission on November 12, 2021 (the “Quarterly Report”).

     

     

     

     

    1

    NAME OF REPORTING PERSONS

    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

     

    Oracle Investment Management, Inc.

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

    (a) ¨

    (b) ¨

    3

    SEC USE ONLY

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    105,885

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    105,885

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    105,885

    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    0.22% *

    12

    TYPE OF REPORTING PERSON (See Instructions)

     

    CO

    * This percentage is based on a total of 48,277,438 Shares outstanding as of November 4, 2021, as reported in the Quarterly Report.

     

     

     

     

    1

    NAME OF REPORTING PERSONS

    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

     

    Oracle Investment Management Inc. Employees Retirement Plan

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

    (a) ¨

    (b) ¨

    3

    SEC USE ONLY

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    105,885

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    105,885

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    105,885

    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    0.22% *

    12

    TYPE OF REPORTING PERSON (See Instructions)

     

    OO

    * This percentage is based on a total of 48,277,438 Shares outstanding as of November 4, 2021, as reported in the Quarterly Report.

     

     

     

     

    1

    NAME OF REPORTING PERSONS

    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

     

    Oracle Partners, LP

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

    (a) ¨

    (b) ¨

    3

    SEC USE ONLY

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    0

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    0

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    0

    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    0% *

    12

    TYPE OF REPORTING PERSON (See Instructions)

     

    PN

    * This percentage is based on a total of 48,277,438 Shares outstanding as of November 4, 2021, as reported in the Quarterly Report.

     

     

     

     

    1

    NAME OF REPORTING PERSONS

    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

     

    Oracle Institutional Partners, LP

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

    (a) ¨

    (b) ¨

    3

    SEC USE ONLY

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    0

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    0

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    0

    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    0% *

    12

    TYPE OF REPORTING PERSON (See Instructions)

     

    PN

    * This percentage is based on a total of 48,277,438 Shares outstanding as of November 4, 2021, as reported in the Quarterly Report.

     

     

     

     

    1

    NAME OF REPORTING PERSONS

    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

     

    Oracle Ten Fund, LP

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

    (a) ¨

    (b) ¨

    3

    SEC USE ONLY

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    0

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    0

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    0

    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    0% *

    12

    TYPE OF REPORTING PERSON (See Instructions)

     

    PN

    * This percentage is based on a total of 48,277,438 Shares outstanding as of November 4, 2021, as reported in the Quarterly Report.

     

     

     

     

    1

    NAME OF REPORTING PERSONS

    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

     

    Oracle Associates, LLC

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

    (a) ¨

    (b) ¨

    3

    SEC USE ONLY

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    0

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    0

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    0

    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    0% *

    12

    TYPE OF REPORTING PERSON (See Instructions)

     

    PN

    * This percentage is based on a total of 48,277,438 Shares outstanding as of November 4, 2021, as reported in the Quarterly Report.

     

     

     

     

    1

    NAME OF REPORTING PERSONS

    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

     

    The Feinberg Family Foundation

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

    (a) ¨

    (b) ¨

    3

    SEC USE ONLY

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    0

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    0

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    0

    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    0% *

    12

    TYPE OF REPORTING PERSON (See Instructions)

     

    OO

    * This percentage is based on a total of 48,277,438 Shares outstanding as of November 4, 2021, as reported in the Quarterly Report.

     

     

     

     

    This Amendment No. 3 to Schedule 13G (this “Amendment No. 3”) is being filed with respect to the Common Stock, par value $0.0001 (“Common Stock”) of Motus GI Holdings, Inc., a Delaware corporation (the “Issuer”), to amend the Schedule 13G filed on December 26, 2018, as previously amended by Amendment No. 1, filed on February 14, 2020 and by Amendment No. 2, filed on February 16, 2021 (as so amended, the “Schedule 13G”), in accordance with the annual amendment requirements. This Amendment No. 3 is being filed on behalf of Oracle Partners, LP, a Delaware limited partnership (“Oracle Partners”), Oracle Ten Fund, LP, a Delaware limited partnership (“Oracle Ten Fund”), Oracle Institutional Partners, LP, a Delaware limited partnership (“Institutional Partners” and, collectively with Oracle Partners and Oracle Ten Fund, the “Oracle Partnerships”), Oracle Investment Management, Inc. Employees’ Retirement Plan, an employee benefit plan organized in Connecticut (the “Retirement Plan”), Oracle Associates, LLC, a Delaware limited liability company and the general partner of the Oracle Partnerships (“Oracle Associates”), Oracle Investment Management, Inc., a Delaware corporation and the investment manager to the Oracle Partnerships and plan administrators to the Retirement Plan (the “Investment Manager”), The Feinberg Family Foundation, a foundation organized in Connecticut (the “Foundation”), and Larry N. Feinberg, the managing member of Oracle Associates, the sole shareholder, director and president of the Investment Manager and the trustee of the Retirement Plan and the Foundation (each of the foregoing, a “Reporting Person” and collectively, the “Reporting Persons”). Capitalized terms used but not defined herein have the meaning ascribed thereto in the Schedule 13G. This Amendment constitutes an exit filing of the Reporting Persons. This Schedule 13G includes all transactions by the Reporting Persons involving shares of the Common Stock through December 27, 2021.

     

    Item 4. Ownership:

     

    A. Larry N. Feinberg

    (a)  Amount beneficially owned: 105,885

    (b)  Percent of class: 0.22%

    (c)  Number of shares as to which such person has:

    (i) Sole power to vote or direct the vote: 0

    (ii) Shared power to vote or direct the vote: 105,885

    (iii) Sole power to dispose or direct the disposition: 0

    (iv) Shared power to dispose or direct the disposition: 105,885

     

    B. Oracle Investment Management, Inc.

    (a)  Amount beneficially owned: 105,885

    (b)  Percent of class: 0.22%

    (c)  Number of shares as to which such person has:

    (i) Sole power to vote or direct the vote: 0

    (ii) Shared power to vote or direct the vote: 105,885

    (iii) Sole power to dispose or direct the disposition: 0

    (iv) Shared power to dispose or direct the disposition: 105,885

     

    C. Retirement Plan

    (a) Amount beneficially owned: 105,885

    (b) Percent of class: 0.22%

    (c) Number of shares as to which such person has:

    (i) Sole power to vote or direct the vote: 0

    (ii) Shared power to vote or direct the vote: 105,885

    (iii) Sole power to dispose or direct the disposition: 0

    (iv) Shared power to dispose or direct the disposition: 105,885

     

    D. Oracle Partners, LP

    (a)  Amount beneficially owned: 0

    (b)  Percent of class: 0%

    (c)  Number of shares as to which such person has:

    (i) Sole power to vote or direct the vote: 0

    (ii) Shared power to vote or direct the vote: 0

    (iii) Sole power to dispose or direct the disposition: 0

    (iv) Shared power to dispose or direct the disposition: 0

     

     

     

     

    E. Oracle Institutional Partners, LP

    (a)  Amount beneficially owned: 0

    (b)  Percent of class: 0%

    (c)  Number of shares as to which such person has:

    (i) Sole power to vote or direct the vote: 0

    (ii) Shared power to vote or direct the vote: 0

    (iii) Sole power to dispose or direct the disposition: 0

    (iv) Shared power to dispose or direct the disposition: 0

     

    F. Oracle Ten Fund, LP

    (a)  Amount beneficially owned: 0

    (b)  Percent of class: 0%

    (c)  Number of shares as to which such person has:

    (i) Sole power to vote or direct the vote: 0

    (ii) Shared power to vote or direct the vote: 0

    (iii) Sole power to dispose or direct the disposition: 0

    (iv) Shared power to dispose or direct the disposition: 0

     

    G. Oracle Associates, LLC

    (a)  Amount beneficially owned: 0

    (b)  Percent of class: 0%

    (c)  Number of shares as to which such person has:

    (i) Sole power to vote or direct the vote: 0

    (ii) Shared power to vote or direct the vote: 0

    (iii) Sole power to dispose or direct the disposition: 0

    (iv) Shared power to dispose or direct the disposition: 0

     

    H. Foundation

    (a)  Amount beneficially owned: 0

    (b)  Percent of class: 0%

    (c)  Number of shares as to which such person has:

    (i) Sole power to vote or direct the vote: 0

    (ii) Shared power to vote or direct the vote: 0

    (iii) Sole power to dispose or direct the disposition: 0

    (iv) Shared power to dispose or direct the disposition: 0

     

     

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Dated: December 29, 2021

     

      /s/ Larry N. Feinberg
      Larry N. Feinberg, Individually
       
      ORACLE PARTNERS, LP
      By: ORACLE ASSOCIATES, LLC, its general partner
         
      By: /s/ Larry N. Feinberg
      Larry N. Feinberg, Managing Member
       
      ORACLE TEN FUND, LP
      By: ORACLE ASSOCIATES, LLC, its general partner
         
      By: /s/ Larry N. Feinberg
      Larry N. Feinberg, Managing Member
       
      ORACLE INSTITUTIONAL PARTNERS, LP
      By: ORACLE ASSOCIATES, LLC, its general partner
         
      By: /s/ Larry N. Feinberg
      Larry N. Feinberg, Managing Member
         
      ORACLE ASSOCIATES, LLC
         
      By: /s/ Larry N. Feinberg
      Larry N. Feinberg, Managing Member
       
      ORACLE INVESTMENT MANAGEMENT, INC.
         
      By: /s/ Larry N. Feinberg
      Larry N. Feinberg, President
         
      ORACLE INVESTMENT MANAGEMENT, INC.
      EMPLOYEES’ RETIREMENT PLAN
         
      By: /s/ Larry N. Feinberg
      Larry N. Feinberg, Trustee
       
      THE FEINBERG FAMILY FOUNDATION
         
      By: /s/ Larry N. Feinberg
      Larry N. Feinberg, Trustee

     

     

     

    Get the next $MOTS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MOTS

    DatePrice TargetRatingAnalyst
    1/25/2023Buy → Neutral
    Ladenburg Thalmann
    More analyst ratings

    $MOTS
    SEC Filings

    See more
    • SEC Form EFFECT filed by Motus GI Holdings Inc.

      EFFECT - Motus GI Holdings, Inc. (0001686850) (Filer)

      8/14/24 12:15:04 AM ET
      $MOTS
      Medical/Dental Instruments
      Health Care
    • SEC Form EFFECT filed by Motus GI Holdings Inc.

      EFFECT - Motus GI Holdings, Inc. (0001686850) (Filer)

      8/14/24 12:15:07 AM ET
      $MOTS
      Medical/Dental Instruments
      Health Care
    • SEC Form EFFECT filed by Motus GI Holdings Inc.

      EFFECT - Motus GI Holdings, Inc. (0001686850) (Filer)

      8/14/24 12:15:02 AM ET
      $MOTS
      Medical/Dental Instruments
      Health Care

    $MOTS
    Leadership Updates

    Live Leadership Updates

    See more
    • EndoSound™ Inc., Appoints Medical Device Commercial Leader Scott Aldrich Jr as Chief Executive Officer

      Aldrich's proven commercial, operational and leadership expertise helps position EndoSound for EVS launch and sustainable growth EndoSound™ Inc., a pioneering medical technology company dedicated to advancing patient care, is pleased to announce the appointment of Scott Aldrich Jr as Chief Executive Officer on February 1st, 2024. Mr Aldrich is joining EndoSound from MotusGI (NASDAQ:MOTS) where he served as Vice President of Commercial and Strategy. Stephen Steinberg MD will remain on the executive leadership team as Chief Medical Officer. Mr Aldrich brings operational and commercial leadership abilities paired with extensive experience in interventional gastroenterology and medical devi

      2/29/24 7:57:00 AM ET
      $MOTS
      Medical/Dental Instruments
      Health Care
    • Motus GI Appoints Medical Device Industry Veteran Scott Durbin to its Board of Directors

      FORT LAUDERDALE, Fla., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ:MOTS) ("Motus GI" or the "Company"), a medical technology company focused on improving endoscopic outcomes and experiences, announced the appointment of Scott Durbin to the Company's Board of Directors (the "Board"). Mr. Durbin has more than 25 years of executive leadership, finance and clinical development experience, including the execution of over $5 billion in financings and merger transactions. In addition, the Company announced that David Hochman and Darren Sherman, independent members of the Board, have stepped down from the Board due to time requirements of their roles as Chief Executive Offi

      9/6/23 5:00:42 PM ET
      $MOTS
      $OBIO
      Medical/Dental Instruments
      Health Care
      Medicinal Chemicals and Botanical Products
    • Orchestra BioMed Appoints Bill Little as Executive Vice President of Corporate Development and Strategy and Andrew Taylor as Chief Financial Officer

      Bill Little, previously Chief Operating Officer (COO) of Neovasc, Inc. through its acquisition by Shockwave Medical in April 2023, will lead efforts to forge further strategic collaborations in newly created Executive Vice President (EVP) of Corporate Development and Strategy role Andrew Taylor joins as Chief Financial Officer (CFO) with over 20 years of CFO experience with emerging growth companies, the last 15 of which were spent in the medical device sector NEW HOPE, Pa., June 07, 2023 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO, "Orchestra BioMed" or the "Company"))), a biomedical company accelerating high-impact technologies to patients through risk-rewa

      6/7/23 8:30:00 AM ET
      $MOTS
      $OBIO
      Medical/Dental Instruments
      Health Care
      Medicinal Chemicals and Botanical Products

    $MOTS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Motus GI Reports First Quarter 2024 Financial Results and Provides Corporate Update

      Successfully ramped up limited U.S. commercial launch of the Pure-Vu® EVS Gastro and Gen 4 Colon system; Doubled the number of active Pure-Vu System customers ordering disposable sleeves with 100% of onboarded customers using Pure-Vu independently Appointed well-known investment bank to identify and evaluate strategic alternatives aimed at accelerating commercialization of the Pure-Vu System and maximizing stockholder value FORT LAUDERDALE, Fla., May 14, 2024 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (OTCQB:MOTS) ("Motus GI" or the "Company"), a medical technology company focused on improving endoscopic outcomes and experiences, today reported its financial results for the first q

      5/14/24 4:05:00 PM ET
      $MOTS
      Medical/Dental Instruments
      Health Care
    • Motus GI Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

      Initiated limited U.S. commercial launch of the Pure-Vu® EVS Gastro and Gen 4 Colon system, including successful UGI procedures at several leading hospital systemsThe Company is engaged in the process to seek strategic partnerships aimed at accelerating commercialization of the Pure-Vu System and maximizing stockholder valueRecent exercise of certain outstanding warrants provided infusion of $2.7M in gross proceeds to the Company, which extended its cash runway into the fourth quarter of 2024 FORT LAUDERDALE, Fla., March 18, 2024 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ:MOTS) ("Motus GI" or the "Company"), a medical technology company focused on improving endoscopic outcomes a

      3/18/24 4:05:00 PM ET
      $MOTS
      Medical/Dental Instruments
      Health Care
    • EndoSound™ Inc., Appoints Medical Device Commercial Leader Scott Aldrich Jr as Chief Executive Officer

      Aldrich's proven commercial, operational and leadership expertise helps position EndoSound for EVS launch and sustainable growth EndoSound™ Inc., a pioneering medical technology company dedicated to advancing patient care, is pleased to announce the appointment of Scott Aldrich Jr as Chief Executive Officer on February 1st, 2024. Mr Aldrich is joining EndoSound from MotusGI (NASDAQ:MOTS) where he served as Vice President of Commercial and Strategy. Stephen Steinberg MD will remain on the executive leadership team as Chief Medical Officer. Mr Aldrich brings operational and commercial leadership abilities paired with extensive experience in interventional gastroenterology and medical devi

      2/29/24 7:57:00 AM ET
      $MOTS
      Medical/Dental Instruments
      Health Care

    $MOTS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Motus GI downgraded by Ladenburg Thalmann

      Ladenburg Thalmann downgraded Motus GI from Buy to Neutral

      1/25/23 9:38:23 AM ET
      $MOTS
      Medical/Dental Instruments
      Health Care

    $MOTS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Motus GI Holdings Inc.

      SC 13G/A - Motus GI Holdings, Inc. (0001686850) (Subject)

      11/14/24 4:22:34 PM ET
      $MOTS
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G filed by Motus GI Holdings Inc.

      SC 13G - Motus GI Holdings, Inc. (0001686850) (Subject)

      2/14/24 3:44:05 PM ET
      $MOTS
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by Motus GI Holdings, Inc. (Amendment)

      SC 13G/A - Motus GI Holdings, Inc. (0001686850) (Subject)

      12/29/21 4:28:32 PM ET
      $MOTS
      Medical/Dental Instruments
      Health Care

    $MOTS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Durbin Scott

      4 - Motus GI Holdings, Inc. (0001686850) (Issuer)

      3/13/24 4:05:19 PM ET
      $MOTS
      Medical/Dental Instruments
      Health Care
    • SEC Form 4 filed by Nelson Sonja

      4 - Motus GI Holdings, Inc. (0001686850) (Issuer)

      3/13/24 8:03:48 AM ET
      $MOTS
      Medical/Dental Instruments
      Health Care
    • SEC Form 4 filed by Pruden Gary J

      4 - Motus GI Holdings, Inc. (0001686850) (Issuer)

      3/13/24 8:02:41 AM ET
      $MOTS
      Medical/Dental Instruments
      Health Care

    $MOTS
    Financials

    Live finance-specific insights

    See more
    • Motus GI Reports First Quarter 2024 Financial Results and Provides Corporate Update

      Successfully ramped up limited U.S. commercial launch of the Pure-Vu® EVS Gastro and Gen 4 Colon system; Doubled the number of active Pure-Vu System customers ordering disposable sleeves with 100% of onboarded customers using Pure-Vu independently Appointed well-known investment bank to identify and evaluate strategic alternatives aimed at accelerating commercialization of the Pure-Vu System and maximizing stockholder value FORT LAUDERDALE, Fla., May 14, 2024 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (OTCQB:MOTS) ("Motus GI" or the "Company"), a medical technology company focused on improving endoscopic outcomes and experiences, today reported its financial results for the first q

      5/14/24 4:05:00 PM ET
      $MOTS
      Medical/Dental Instruments
      Health Care
    • Motus GI Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

      The Company continues its exploration process to target strategic and financing alternatives aimed at accelerating commercialization of the Pure-Vu System and maximizing stockholder valueThe Company is actively supporting its existing installed customer base and pipeline opportunities in contracted health systems  The Company is advancing its development of Pure-Vu EVS Gastro, designed for Upper GI bleeding procedures, and expects submission to FDA by the end of 2023 FORT LAUDERDALE, Fla., March 31, 2023 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ:MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve clinical outcomes and e

      3/31/23 4:05:00 PM ET
      $MOTS
      Medical/Dental Instruments
      Health Care
    • Motus GI Reports Third Quarter 2022 Financial Results and Provides Business Update

      Pure-Vu EVS approved for use at 25 hospitals since launch in March 2022, resulting in highest quarterly revenue reported in the Company's historyRecently named a Sole Source Supplier by the Department of Veteran's Affairs, with several VA medical centers executing new contracts for Pure-Vu EVS systems under this designationPresented positive clinical data in three abstracts at the American College of Gastroenterology (ACG) 2022 Annual Scientific Meeting that further illustrate how Pure-Vu EVS is enabling physicians to significantly improve visualization during colonoscopy procedures across different settings and patient populations FORT LAUDERDALE, Fla., Nov. 14, 2022 (GLOBE NEWSW

      11/14/22 4:05:00 PM ET
      $MOTS
      Medical/Dental Instruments
      Health Care